Early Switch in Moderate ARDS (SWITCH-ARDS)
Early Switch to Assisted Ventilation in Patients With Moderate ARDS: a Physiological Study
The optimal timing for transition from controlled to assisted mechanical ventilation in patients with acute respiratory distress syndrome (ARDS) remains uncertain. Excessive spontaneous respiratory effort may promote injurious transpulmonary pressure swings and heterogeneous regional ventilation, whereas unnecessary prolongation of controlled ventilation may increase sedation exposure and diaphragmatic dysfunction.
This prospective, single-center physiological interventional study will enroll mechanically ventilated adults with ARDS and a PaO₂/FiO₂ ratio >100 and ≤200 mmHg, measured during PEEP=5 cmH2O, who are receiving controlled mechanical ventilation. Participants will undergo a protocolized 30-minute transition from controlled to assisted mechanical ventilation after reduction of sedation sufficient to allow spontaneous respiratory activity.
Respiratory effort and drive, airway and esophageal pressures, respiratory flow, respiratory mechanics, gas exchange, and regional ventilation measured by electrical impedance tomography will be assessed before and during the transition. Participants will subsequently be followed for 48 hours to determine whether assisted ventilation can be maintained without return to fully controlled mechanical ventilation.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
Participants meeting eligibility criteria will initially remain on their clinically prescribed controlled mechanical ventilation. Sedation will be gradually reduced to permit the reappearance of spontaneous respiratory activity while avoiding clinically significant agitation or patient-ventilator dyssynchrony. Once spontaneous respiratory activity is present, participants will be transitioned to assisted mechanical ventilation. Positive end-expiratory pressure will be maintained at the pre-transition level, which will have been titrated with the use of esophageal manometry so as to achieve an end-expiratory trans-pulmonary pressure above 0 cmH2O, and inspired oxygen fraction will remain unchanged whenever clinically feasible. Inspiratory assistance will be titrated to maintain protective targets: esophageal pressure swings= 3-15 cmH2O (diaphragm protective) and transpulmonary pressure swings < 15-20 cmH2O (lung protective).
The physiological transition trial will last 30 minutes. Continuous recordings of airway pressure, esophageal pressure, respiratory flow, and electrical impedance tomography will be obtained. Respiratory drive will additionally be assessed using airway occlusion pressure at 100 milliseconds (P0.1).
Three prespecified analysis periods will be used: T0, the final 5 minutes during controlled ventilation before transition; T1, the first 5 minutes of assisted ventilation; and T2, minutes 25-30 of assisted ventilation.
Electrical impedance tomography analyses will include regional distribution of tidal ventilation, global inhomogeneity index, end-expiratory lung impedance, ventral-to-dorsal ventilation distribution, center of ventilation, and occurrence or magnitude of pendelluft. Respiratory mechanics analyses will include esophageal pressure swing, pressure-time product of the esophageal pressure, transpulmonary pressure, respiratory system elastance, chest-wall elastance, and lung elastance.
The transition trial will be stopped if prespecified clinical intolerance or safety criteria occur. Participants who do not tolerate the trial will be returned to controlled ventilation according to clinical requirements.
After completion of the 30-minute trial, participants will be followed for 48 hours. Successful transition will be defined as maintenance of assisted mechanical ventilation without the need to return to fully controlled mechanical ventilation during this period.
Studietype
Studietype
Registrering (Antatt)
Registrering
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Apostolos - Alkiviadis Menis, MD, PhD
- Telefonnummer: +30 2413501280
- E-post: menis.ap.alk@proton.me
Studer Kontakt Backup
- Navn: Demosthenes Makris, MD, PhD
- Telefonnummer: +30 2413501280
- E-post: dimomakris@med.uth.gr
Studiesteder
-
-
-
Larissa, Hellas
- Rekruttering
- Critical Care Department, University Hospital of Larisa
-
Ta kontakt med:
- Apostolos Menis, MD, PhD
- Telefonnummer: +30 2413 501278
- E-post: menis.ap.alk@gmail.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Patients with ARDS of severe to moderate severity (100<PaO2/FiO2<200 mmHg).
Beskrivelse
Inclusion Criteria:
- Age ≥18 years
- Endotracheally intubated and receiving invasive mechanical ventilation
- Meets diagnostic criteria for acute respiratory distress syndrome
- PaO₂/FiO₂ ratio >100 and ≤200 mmHg
- Receiving controlled mechanical ventilation immediately before the transition trial
Exclusion Criteria:
- Implanted electrical cardiac or other device incompatible with electrical impedance tomography
- Thoracic drains, extensive dressings, or other factors preventing appropriate EIT belt placement
- Contraindication to placement of an esophageal balloon catheter
- Active neuromuscular blockade at initiation of the transition trial
- Significant hemodynamic instability
- Any clinical condition for which reduction of sedation or transition to assisted ventilation is considered unsafe by the treating physician
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Antall grupper / kohorter
Kohorter og intervensjoner
Gruppe / KohortGruppe / Kohort |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Experimental: Protocolized Transition to Assisted Mechanical Ventilation
|
Participants receiving controlled mechanical ventilation will undergo gradual reduction of sedation to permit spontaneous respiratory activity, followed by a 30-minute transition to assisted mechanical ventilation. PEEP will remain at the pre-transition value and FiO₂ will remain unchanged whenever clinically feasible. Inspiratory assistance will be titrated to maintain tidal volume at approximately 6-8 mL/kg predicted body weight. Physiological measurements will be recorded continuously, and the procedure will be terminated if prespecified intolerance or safety criteria occur. |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Tidsramme: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. We will measure respiratory rate (breaths per minute). |
During the first thirty minutes of assisted ventilation.
|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Tidsramme: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. The measured variables will include the lung elastance, the chest wall elastance and the total respiratory system elastance (all measured in cmH₂O/L). |
During the first thirty minutes of assisted ventilation.
|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Tidsramme: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. The measured variables will include the transpulmonary pressure, which is measured in cmH₂O. During the baseline measurement both statics and dynamics measurements will be calculated, whereas during the assisted phase the investigator will include only the dynamic measurements. |
During the first thirty minutes of assisted ventilation.
|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Tidsramme: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. We will measure tidal volume (mLs). |
During the first thirty minutes of assisted ventilation.
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Tidsramme: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the variation in the global inhomogeneity index derived by using electrical impedance tomography. |
During the first thirty minutes of assisted ventilation.
|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Tidsramme: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the end-expiratory lung impedance, EELI, which is measured in ohms. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Tidsramme: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the ventral to dorsal ratio using the electrical impedance tomography. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Tidsramme: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the variation in the pendelluft phenomenon using the impedance amplitude values. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in respiratory effort between successful and failed transition to assisted ventilation
Tidsramme: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the differences in esophageal pressure swings, ΔPes in cmH₂O, between the beginning of the transition phase and at the final 5 minutes of the 30-minute trial. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in respiratory effort between successful and failed transition to assisted ventilation.
Tidsramme: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the differences in the esophageal pressure-time product measured in cmH₂O⋅s/min, between the beginning of the transition phase and at the final 5 minutes of the 30-minute trial. |
During the first 30-minutes of assisted ventilation.
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Hovedetterforsker: Apostolos - Alkiviadis Menis, MD, PhD, General University Hospital of Larisa, University of Thessaly
- Studieleder: Makris, MD, PhD, General University Hospital of Larisa, University of Thessaly
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- SWITCH_MODERATE_ARDS
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .